April 24, 2025

ASCO Updates Guideline for Fertility Preservation in People With Cancer

ASCO has released an update to the guideline for fertility preservation in people with cancer. The update, recently published in the Journal of Clinical Oncology,1 provides recommendations regarding e...

The ASCO Post

April 24, 2025

Combination Therapy for Newly Diagnosed, BRCA-Nonmutated, Advanced Epithelial Ovarian Cancer

The outcomes from the phase III ENGOT-OV43/GOG-3036/KEYLYNK-001 trial in advanced BRCA-nonmutated ovarian cancer indicate a statistically significant and clinically meaningful benefit for the PD-1 inh...

The ASCO Post

April 22, 2025

Role of Pathologists in Improving Access to Safer, More Effective Allogeneic Cell Therapies

Researchers are working to accelerate the clinical adoption of novel allogeneic cell therapies to improve cancer care and treatment.

The ASCO Post

April 17, 2025

Renowned Breast Cancer Physician-Scientist Hope S. Rugo, MD, FASCO, to Lead Women’s Cancers Program at City of Hope

She will lead and enhance women’s cancers research and clinical care across the enterprise, expand clinical trials and translational research, and standardize cancer care to achieve superior patient o...

The ASCO Post

November 27, 2023

Expert Point of View: Helena Linardou, MD, PhD

Dr. Linardou presents promising findings on TROP-2-targeting agents for lung cancer at the 2023 World Conference on Lung Cancer, highlighting the potential to replace chemotherapy in first-line combinations.

The ASCO Post

June 16, 2023

Study Evaluates Clinical Utility of Novel Liquid Biopsy-Breast Cancer Methylation Prototype Assay

A novel, automated liquid biopsy test—the Liquid Biopsy for Breast Cancer Methylation assay—may be effective at predicting early disease progression and potential survival outcomes in patients with me...

The ASCO Post

July 12, 2023

Changing How Immune Checkpoint Inhibitors Are Delivered Could Reduce Costs by 14%, Study Finds

Investigators have found that millions of dollars could be saved annually across the Veterans Health Administration by reconsidering how immune checkpoint inhibitors are delivered, according to a new ...

The ASCO Post

February 19, 2024

FDA Grants Accelerated Approval to Lifileucel for Unresectable or Metastatic Melanoma

On February 16, the FDA granted accelerated approval to lifileucel (Amtagvi), a tumor-derived autologous T-cell immunotherapy, for previously treated adult patients with unresectable or metastatic mel...

The ASCO Post

March 22, 2023

The Importance of Professional Communities and Collaborations

The complexity of cancer care requires unique skill sets that must be cultivated. Collaborating with professionals specializing in different areas ensures comprehensive and patient-centered care. A mu...

JADPRO